These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17300301)

  • 1. Cost evaluation in the intensive care units of Trinidad applying the cost-blocks method - an international comparison.
    Hariharan S; Chen D; Merritt-Charles L
    Anaesthesia; 2007 Mar; 62(3):244-9. PubMed ID: 17300301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the intensive care unit resources and utilization in Trinidad.
    Hariharan S; Chen D; Merritt-Charles L; Bobb N; De Freitas L; Esdelle-Thomas A; Mohamed J; Charles D; Colley K; Renaud E
    West Indian Med J; 2007 Mar; 56(2):144-51. PubMed ID: 17910145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative costing analysis of intensive care services between Hungary and United Kingdom.
    Csomós A; Janecskó M; Edbrooke D
    Intensive Care Med; 2005 Sep; 31(9):1280-3. PubMed ID: 15959758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in patient routine costliness in U.S. psychiatric facilities.
    Cromwell J; Drozd EM; Gage B; Maier J; Richter E; Goldman HH
    J Ment Health Policy Econ; 2005 Mar; 8(1):15-28. PubMed ID: 15870482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
    Davies A; Ridley S; Hutton J; Chinn C; Barber B; Angus DC
    Anaesthesia; 2005 Feb; 60(2):155-62. PubMed ID: 15644013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units.
    Moerer O; Plock E; Mgbor U; Schmid A; Schneider H; Wischnewsky MB; Burchardi H
    Crit Care; 2007; 11(3):R69. PubMed ID: 17594475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economies of scale in British intensive care units and combined intensive care/high dependency units.
    Jacobs P; Rapoport J; Edbrooke D
    Intensive Care Med; 2004 Apr; 30(4):660-4. PubMed ID: 14997294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of intensive care: a comparison on one unit between 1988 and 1991.
    Singer M; Myers S; Hall G; Cohen SL; Armstrong RF
    Intensive Care Med; 1994 Nov; 20(8):542-9. PubMed ID: 7706565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of intensive therapy. A description of methodology and initial results.
    Ridley S; Biggam M; Stone P
    Anaesthesia; 1991 Jul; 46(7):523-30. PubMed ID: 1862888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A method to determine hospital costs associated with nosocomial infections].
    Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
    Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, duration and cost of futile treatment in end-of-life hospital admissions to three Australian public-sector tertiary hospitals: a retrospective multicentre cohort study.
    Carter HE; Winch S; Barnett AG; Parker M; Gallois C; Willmott L; White BP; Patton MA; Burridge L; Salkield G; Close E; Callaway L; Graves N
    BMJ Open; 2017 Oct; 7(10):e017661. PubMed ID: 29038186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective audit of cost of sedation, analgesia and neuromuscular blockade in a large British ICU.
    Al-Haddad M; Hayward I; Walsh TS
    Anaesthesia; 2004 Nov; 59(11):1121-5. PubMed ID: 15479323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective costs of intensive care: TISS and TISS-28 for the evaluation of an intensive care unit].
    Lefering R; Zart M; Neugebauer E
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1393-5. PubMed ID: 9574439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and Utilization of Operating Rooms in a Public Hospital in Trinidad, West Indies.
    Hariharan S; Chen D
    Perm J; 2015; 19(4):e128-32. PubMed ID: 26828072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Federal and nationwide intensive care units and healthcare costs: 1986-1992.
    Halpern NA; Bettes L; Greenstein R
    Crit Care Med; 1994 Dec; 22(12):2001-7. PubMed ID: 7988140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Programme for Resource Use in Critical Care (IPOC)--a methodology and initial results of cost and provision in four European countries.
    Negrini D; Sheppard L; Mills GH; Jacobs P; Rapoport J; Bourne RS; Guidet B; Csomos A; Prien T; Anderson G; Edbrooke DL
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):72-9. PubMed ID: 16451154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable cost of ICU care, a micro-costing analysis.
    Karabatsou D; Tsironi M; Tsigou E; Boutzouka E; Katsoulas T; Baltopoulos G
    Intensive Crit Care Nurs; 2016 Aug; 35():66-73. PubMed ID: 27080569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profit and loss analysis for an intensive care unit (ICU) in Japan: a tool for strategic management.
    Cao P; Toyabe S; Abe T; Akazawa K
    BMC Health Serv Res; 2006 Jan; 6():1. PubMed ID: 16403235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.